L222P (p.Leu222Pro) variant of ITGB3 (Integrin beta-3)
L222P (p.Leu222Pro) in ITGB3 (Integrin beta-3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Glanzmann thrombasthenia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.76 / 1. The record also includes population frequency data, published literature, and structural context.
L222P (p.Leu222Pro) variant details
- p.Leu222Pro
- rs79208797
- ClinGen CA291224887
- ClinVar RCV001290457
- ClinVar RCV002254211
- Pathogenic
- Glanzmann thrombasthenia
- Missense
- Variant Prioritization Score for Impact Estimate 0.763
- MetaLR 0.95
- MetaSVM 1.10
- CADD 29.30
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Pathogenic (Glanzmann thrombasthenia)
- EBI: Pathogenic (in GT2)
- UniProt: Pathogenic (in GT2)
- Population evidence available
- Structural context available
- Cited in: A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form… (PMID 11897046)
- Cited in: AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing… (PMID 20020534)